Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA, EMA Lay Out Incretin Mimetic Safety Analysis In NEJM

Related Content

FDA’s “Early Communication” On Pancreatitis Risk For Incretin Mimetics Draws Clinician Ire

Mar 15 2013

Related Companies

AstraZeneca PLC

Bristol Myers Squibb Company

Novo Nordisk A/S

Sanofi

Merck & Co., Inc.

Boehringer Ingelheim GmbH

Eli Lilly and Company

Takeda Pharmaceutical Co. Ltd.

Novartis AG

Additional Topics

United States Europe Safety BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window